Last Min MRCP revision Part -C

MRCP last min Revision notes
Lsteriosis = Amoxicillin

Genital herps ulcer (recurrent but healed ) : Acyclovir 400 mg tid till 36 weeks
If not healed ulcer acyclovir till delivery


To  D b/w membranous GN from chronic  tubulo-interstitial GN in pt take chronic NSAIDS by proteinuria marked in MGN


SeHCAT test : investigation for bile acid Malabsoption / diarrhea



 Drugs causing lung fibrosis
amiodarone
cytotoxic agents: busulphan, bleomycin
anti-rheumatoid drugs: methotrexate, sulfasalazine, gold
nitrofurantoin
ergot-derived dopamine receptor agonists (bromocriptine, cabergoline, pergolide)


Pyrazinamide Should NOT be used in pts with known chronic liver dx...🚫


Rx of CF▶exocrine pancreatic supplements+ fat-soluble vitamins...


 Rx of systemic sclerosis associated lung fibrosis ➡high dose oral corticosteroids + cyclophosphamide.



Tense blistering itchy rash in apt with NSTEMI▶Bullous pimphigoid caused by Furosemide 😡


 Ludwig's angina Rx▶iv antibiotics against strept & oral anaerobes + call anaesthesist..



 Prophylaxis for TB in HIV pt with exposure Hx▶INH900mg+ pyridoxine 100mg twice weekly for 9 monthsπŸ‘Ž


Chronic COPD▶CO2 retention in the presence of NORMAL pH. If there is worsening acidosis ▶Acute exacerbation of COPD✅


TRALI▶anti-granulocyte antibodies in the donor bloodπŸ‘Œ


 ICDs▶reduce risk of sudden death in HOCM with VT.....


πŸ“ŒπŸ“ŒπŸ“Œ
Thrombolysis in stroke within 4.5 h
Thrombolysis in mi within 12 hours
Pci within 120 min!!!!
?????
Correct me plzzz
Pci also 12 hrs. But best door to needle less than 2 hrs i think.✔✔


 Fever+headache+tender lymphadenopathy following an insect bite in Madagascar.
Dx and Rx?

Ans is Bubonic plague
Y.pestis.🍏
Bubonic plaques ◀ Yersinia Pestis.
Rx>>> Streptomycin.✔


✔πŸ“Œ
In stroke we dont give statin in 48 hours and aticoagulation in 14 days
Only aspirin.πŸ‘Œ


Omalizumab⏩ ttt of IgE -associated asthma.✔


To reverse the anticoagulant effect of Dabigatran rapidly πŸ”œ Idarucizumab.⭕


Roflumilast ⏯should be used in COPD for patients who are losing control on triple inhaled therapy
Roflumilast is a selective long-acting phosphodiesterase-4 inhibitor, licensed for the treatment of COPD. With respect to NICE guidance it is recommended for patients who have suffered two or more exacerbations in a year, despite triple inhaled therapy, where FEV1 is less than 50% of predicted. It is orally administered.

Comments

Popular posts from this blog

KEY points passmedicine for part-1 and part-2 (part-c)

KEY points pass medicine for part -1 and part-2 (part-b)